Delivery Order SPE2DB22D9316-SPE2DB24FYN27

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a 14 milliliter vial of the drug Perjeta (420 milligrams). The delivery order has a potential value of $21,274.80 and a completion date of January 24, 2024. This award is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. to supply various pharmaceuticals and medical supplies to support military treatment...

The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a 420 mg/14 ml vial of the drug Perjeta. The order, valued at $112,320.24, was placed on September 20, 2021, with a completion date of October 12, 2021. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals...

The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a 14 milliliter vial of the drug Perjeta at a potential value of $25,529.76. The delivery order has a completion date of January 30, 2024. DMS Pharmaceutical Group is a prime vendor for the Defense Logistics Agency, providing a variety of pharmaceutical and medical products to military treatment facilities worldwide under...

The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a 14 milliliter vial of the prescription drug Perjeta (420 milligrams) with a potential value of $42,549.60. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA Troop Support Medical to supply various pharmaceutical and medical products, valued up to $5 million, in...

The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 420 mg/14 ml vials of the drug Perjeta. The delivery order has a potential value of $102,119.04 and a completion date of January 31, 2024. This contract award is part of a larger indefinite delivery contract with DMS Pharmaceutical Group to supply a variety of pharmaceutical and medical products to military treatment...

The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to supply the pharmaceutical product Perjeta 420 mg/14 ml vial. The order has a potential value of $8,277.00 and a completion date of January 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the...

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-four thousand eight hundred thirty-one dollars by the Defense Logistics Agency under an existing indefinite delivery contract. The delivery order is for the supply of fourteen milliliter vials of Perjeta 420 mg to Defense Logistics Agency Troop Support Medical facilities. As a woman-owned small business, DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract through December 2025...

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a 14 milliliter vial of the cancer drug Perjeta (pertuzumab) with a potential value of $34,039.68. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. to supply a variety of pharmaceutical and medical products, including items such as flumazenil, prednisone, and...

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,254.96 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Perjeta 420 mg/14 ml vials. This order is part of a larger indefinite delivery contract, SPE2DB, valued at up to $4,999,999 through 2025, which enables DLA to issue delivery orders for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities...

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $8,509.92, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the oncology drug Perjeta (pertuzumab) 420 mg/14 mL vial, with an ultimate completion date of October 10, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...